| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Editas Medicine, Inc. (EDIT) has 3 insiders with recent SEC Form 4 filings, including 1 buy and 10 sells. EDIT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 269.1K | $780.4K | - | |
| VP | 62.4K | $180.9K | -4,928 | |
| CFO | 15.9K | $46.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 6, 2020 | Albright Charles | Evp/ Chief Scientific Officer | Sell | 151 | $25.28 | $3,817.28 | -0.5% | |
| Feb 7, 2020 | Albright Charles | Chief Scientific Officer | Sell | 622 | $26.95 | $16,762.90 | -1.9% | |
| Feb 3, 2020 | Albright Charles | Chief Scientific Officer | Sale+OE | 5,549 | $26.54 | $147,287.66 | -21.3% | |
| Aug 19, 2019 | Collins Cynthia | CEO | Sell | 5,193 | $25.83 | $134,135.19 | -31.3% | |
| Mar 18, 2019 | Myer Vickesh | Chief Technology Officer | Sale+OE | 3,000 | $24.50 | $73,500.00 | -100% | |
| Mar 5, 2019 | Hopfield Jessica | Director | Buy | 10,200 | $23.94 | $244,188.00 | +152.2% | |
| Feb 20, 2019 | Myer Vickesh | Chief Technology Officer | Sale+OE | 3,000 | $20.42 | $61,260.00 | -100% | |
| Feb 4, 2019 | Hack Andrew A. F.62 | Chief Financial Officer | Sale+OE | 6,895 | $21.39 | $147,484.05 | -100% | |
| Jan 18, 2019 | Myer Vickesh | Chief Technology Officer | Sale+OE | 7,000 | $26.36 | $184,540.00 | -100% | |
| Jan 8, 2019 | Bosley Katrine | President And CEO | Sell | 12,000 | $25.27 | $303,240.00 | -1.0% |